研究者氏名	三原圭一朗

URL
所属	藤田医科大学
部署	国際再生医療センター/先進がん免疫療法学
職名
学位	博士（医学）(広島大学)
科研費研究者番号	90363077
J-Global ID	201801010876392945

研究分野

ライフサイエンス / 血液、腫瘍内科学 /

学歴

1992年4月

1996年3月

広島大学医学系研究科内科系専攻

論文

<2 345 6 >

Metastatic Malignant Lymphoma Mimicking Cerebral Toxoplasmosis with the "Target Sign"

Ueno Hiroki Maruyama Hirofumi Norose Kazumi Kamimura Teppei Mihara Keichiro Yamasaki Fumiyuki Hikosaka Kenji J. Amatya Vishwa Takeshima Yukio Kurisu Kaoru

Internal Medicine 58(8) 1157-1162 2019年 [査読有り]

<p>We herein report the case of a 60-year-old man with a "target sign" in the left frontal lobe on magnetic resonance imaging (MRI), which is thought to be a specific sign of cerebral toxoplasmosis. ¹⁸F-fluorodeoxyglucose-positron emiss...

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma.

Yanagihara K Kubo T Mihara K Kuwata T Ochiai A Seyama T Yokozaki H

Oncotarget 9(92) 36503-36514 2018年11月 [査読有り]

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial.

Ken Ohmachi Kensei Tobinai Tomohiro Kinoshita Takayuki Ishikawa Kiyohiko Hatake Satoshi Ichikawa Ken Ohmine Yuri Kamitsuji Ilseung Choi Takaaki Chou Kunihiro Tsukasaki Kyoya Kumagai Masafumi Taniwaki Toshiki Uchida Yoshitaka Kikukawa Kohmei Kubo Keichiro Mihara Norifumi Tsukamoto Koji Izutsu Isao Yoshida Fumihiro Ishida Noriko Usui Shinsuke Iida Tohru Murayama Eisuke Ueda Hiroshi Kuriki Kiyoshi Ando

International journal of hematology 108(5) 499-509 2018年11月

GALLIUM is a global phase III study that demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) with obinutuzumab plus chemotherapy (G-chemo) versus rituximab plus chemotherapy (R-chemo) i...

Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma

Tari, Akira Kitadai, Yasuhiko Mouri, Ritsuo Takigawa, Hidehiko Asaoku, Hideki Mihara, Keiichiro Takata, Katsuyoshi Fujihara, Megumu Yoshino, Tadashi Koga, Tadashi Fujimori, Shunji Tanaka, Shinji Chayama, Kazuaki

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 33(8) 1461-1468 2018年8月 [査読有り]

Background and AimFew reports have demonstrated the effectiveness of treatments for intestinal follicular lymphoma (FL) because of the limited number of patients who undergo comprehensive small intestinal examinations. This study compared the effi...

MicroRNAs Associated with Epithelial-Mesenchymal Transition Can Be Targeted to Inhibit Peritoneal Dissemination of Human Scirrhous Gastric Cancers.

Yoshifumi Takei Guodong Shen Ayami Morita-Kondo Toshifumi Hara Keichiro Mihara Kazuyoshi Yanagihara

Pathobiology : journal of immunopathology, molecular and cellular biology 85(4) 232-246 2018年

OBJECTIVES: Scirrhous gastric cancers grow rapidly, and frequently invade the peritoneum. Such peritoneal dissemination properties markedly reduce patient survival. Thus, an effective means for inhibiting peritoneal dissemination is urgently requi...